Build info

Synonyms

Short Name

Procedure Master Number

Procedure ID

Clinical Info

This test screens for open spina bifida. This test does not screen for Down syndrome or trisomy 18. The following information must be provided: gestational age, 
date on which the patient was the stated gestational age, how gestational age was determined (LMP, EDD, US), patient's weight, patient's date of birth, 
patient's race (white, black, other), and insulin-dependent diabetic status. Also indicate relevant patient history, such as prior neural tube defects, ultrasound anomalies, 
or previous maternal serum screening during this pregnancy. Complete information is necessary to interpret the test.. Specimens must be collected before amniocentesis.
Open spina bifida screening is offered for gestational ages 15.0 to 23.9 weeks. The optimal gestational age for open spina bifida screening is 16.0 to 18.9 weeks.
Limitations
MS-AFP is a screening test. This test does not screen for Down syndrome or trisomy 18. A positive result means that more diagnostic testing may be offered to the 
pregnant woman to determine if a neural tube defect is present.
This test was developed and its performance characteristics determined by Labcorp. It has not been cleared or approved by the Food and Drug Administration.

Specimen Sources

Specimen Types

Container

Gold Top Tube

Collection Instructions

Container/Tube: Gold top tube
Specimen: 3 mL serum ( 0.5 min)
Transport Temperature: Room Temperature
Special Instructions
This test screens for open spina bifida. This test does not screen for Down syndrome or trisomy 18.
The following information must be provided:
1) gestational age,
2) date on which the patient was the stated gestational age,
3) how gestational age was determined (LMP, EDD, US),
4) patient's weight,
5) patient's date of birth,
6) patient's race (white, black, other),
7) Also indicate relevant patient history, such as prior neural tube defects, ultrasound anomalies, or previous maternal
serum screening during this pregnancy.
Complete information is necessary to interpret the test. Patient information may be provided to the laboratory
Specimens must be collected before amniocentesis.
Open spina bifida screening is offered for gestational ages 15.0 to 23.9 weeks.
The optimal gestational age for open spina bifida screening is 16.0 to 18.9 weeks.

Transport Instructions

Room Temperature

Specimen Stability

7 Days Room Temperature
14 Days Refrigerated or Frozen

Methodology

Chemiluminescent immunoassay

Days Performed

TAT 3- 6 Days

Performing Laboratory

Labcorp RTP

CPT

82105
LOINC Code: 48802-3

PDM

Only Orderable at Locations:

Results